Primate Monocytes - CD14, CD16 - Ziegler-Heitbrock

Contact

Associations Between Gastroenteropancreatic Neuroendocrine Neoplasms and Inflammatory Factors: Insights From a Two-Sample Mendelian Randomization Analysis.

Abstract

Purpose: Inflammation is implicated in the pathogenesis of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs); however, the causal nature of this association remains unclear. This study sought to evaluate the causal relationships between GEP-NENs and inflammatory factors using a two-sample Mendelian randomization (MR) approach. Methods: We performed a two-sample MR analysis to investigate the causal associations between 91 inflammatory proteins and 731 immune cell traits as exposures and the five subtypes of GEP-NENs as the outcomes. The analytical approach employed various methodologies, such as inverse variance weighting, MR-Egger, weighted mode, weighted median, and simple mode. To evaluate the robustness of the results, sensitivity analyses were conducted, which encompassed MR Egger regression, MR multiple gene residual and outlier detection, leave-one-out analysis, and Cochran's Q test. False discovery rate (FDR) correction was applied, and causal relationships at the gene level were deemed significant at p < 0.05 after FDR adjustment. Results: After FDR correction, the findings revealed robust causal associations between genetically predicted HLA DR++ monocyte %leukocyte (OR = 3.09, 95% CI: 1.76-5.44, p < 0.001, FDR = 0.022), HLA DR on CD14+ CD16- monocyte (OR = 1.72, 95% CI: 1.34-2.22, p < 0.001, FDR = 0.010), and HLA DR on CD14+ monocyte (OR = 1.76, 95% CI: 1.36-2.29, p < 0.001, FDR = 0.010) and genetically predicted stomach NENs. Reverse analysis revealed that GEP-NENs had no major impact on inflammation. Conclusion: These findings reveal the immune mechanisms underlying GEP-NENs and highlight potential therapeutic strategies targeting the immune microenvironment of GEP-NENs.

Authors: Guo H, Li Y, Liu B, Liu S,
Journal: Can J Gastroenterol Hepatol;2025; 2025 2591387. doi:10.1155/cjgh/2591387
Year: 2025
PubMed: PMID: 41458898 (Go to PubMed)